MIR4706

Across TCGA pan-cancer cohorts, MIR4706 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of MIR4706’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where MIR4706 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4706 is over-expressed in tumor, although a few such as LUAD show the opposite, repressed pattern.

BLCA, KIRC, and LIHC are the cancer types where MIR4706 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR4706 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	III,IV	+0.762	.008	6	view →
KIRC	All	II,III,IV	+0.115	.018	2	view →
LIHC	Male	All	+0.097	.041	2	view →
ESCA	Female	All	+0.459	.013	1	view →
LUAD	Female	II,III,IV	−0.403	.022	1	view →
LUSC	Male	All	+0.268	.020	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

MIR4706–BLCA

Open the BLCA breakdown →